Ondine Biomedical Inc.
OBIMF
$0.11
-$0.02-15.39%
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.48% | 11.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.48% | 11.87% | |||
| Cost of Revenue | -1.47% | 3.12% | |||
| Gross Profit | -1.48% | 18.12% | |||
| SG&A Expenses | -1.47% | 20.86% | |||
| Depreciation & Amortization | -1.49% | -0.49% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.47% | 16.14% | |||
| Operating Income | 1.47% | -16.62% | |||
| Income Before Tax | 1.47% | -20.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.47% | -20.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.47% | -20.28% | |||
| EBIT | 1.47% | -16.62% | |||
| EBITDA | 1.47% | -16.83% | |||
| EPS Basic | 1.68% | -12.26% | |||
| Normalized Basic EPS | 2.67% | -8.70% | |||
| EPS Diluted | 1.68% | -12.26% | |||
| Normalized Diluted EPS | 2.67% | -8.70% | |||
| Average Basic Shares Outstanding | 0.00% | 6.49% | |||
| Average Diluted Shares Outstanding | 0.00% | 6.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
